SION
Sionna Therapeutics, Inc.NASDAQHealthcare$40.49-1.96%ClosedMarket Cap: $1.82B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.87
P/S
0.00
EV/EBITDA
-21.69
DCF Value
$1.23
FCF Yield
-4.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-22.9%
ROA
-23.1%
ROIC
-28.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-23.6M | $-20.4M | $-0.46 | — |
| FY 2025 | $0.00 | -Infinity% | $-89.0M | $-75.3M | $-1.88 | — |
| Q3 2025 | $0.00 | -Infinity% | $-23.8M | $-20.3M | $-0.46 | — |
| Q2 2025 | $0.00 | -Infinity% | $-21.9M | $-18.1M | $-0.41 | — |
| Q1 2025 | $0.00 | NaN% | $-19.7M | $-16.5M | $-0.37 | — |
| Q4 2024 | $0.00 | NaN% | $-18.1M | $-15.8M | $-0.36 | — |
| FY 2024 | $0.00 | -Infinity% | $-70.6M | $-61.7M | $-1.40 | — |
| Q3 2024 | $0.00 | NaN% | $-28.0M | $-25.4M | $-0.58 | — |
| Q2 2024 | $0.00 | -Infinity% | $-11.3M | $-8.6M | $-0.19 | — |
| Q1 2024 | $0.00 | NaN% | $-13.1M | $-11.8M | $-0.27 | — |
| Q4 2023 | $0.00 | NaN% | $-12.6M | $-11.9M | $-0.27 | — |
| FY 2023 | $0.00 | NaN% | $-50.3M | $-47.3M | $-1.07 | — |